Killer T cells recognize cancer in pre-clinical tumors, but are silenced as tumor develops
One of the challenges for developing truly successful immunotherapies is that cancer is a wily foe for the immune system. Tumors have multiple lines of defense against our immune cells' attempts to attack them. Although our ...
Aug 9, 2016
0
8